Clinical Utility of Tumor Next-Generation Sequencing Panel Testing to Inform Treatment Decisions for Patients With Advanced Solid Tumors in a Tertiary Care Center Chemotherapy-induced peripheral ...

The US has a diabetic wound problem. An estimated 1 million patients with diabetes in the US develop a foot ulcer annually.

The study aims to assess the efficacy of nucresiran in improving neurologic impairment, quality of life, nutritional status, disability, and gait speed in patients ... hereditary transthyretin ...

Premature mortality is independently and additively associated with peripheral neuropathy and hearing loss, both of which are common in older patients. Hearing loss and peripheral neuropathy are ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the HELIOS-A Phase 3 study of vutrisiran, an ...